Ameriprise’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-45,094
Closed -$427K 4108
2025
Q3
$427K Buy
+45,094
New +$380K ﹤0.01% 3681
2024
Q2
Sell
-51,803
Closed -$917K 3879
2024
Q1
$917K Buy
+51,803
New +$820K ﹤0.01% 3199
2023
Q4
Sell
-154,345
Closed -$2.12M 3911
2023
Q3
$2.12M Sell
154,345
-44,016
-22% -$648K ﹤0.01% 2788
2023
Q2
$3.42M Buy
198,361
+1,665
+0.8% +$34.1K ﹤0.01% 2597
2023
Q1
$4.72M Buy
196,696
+157,364
+400% +$3.42M ﹤0.01% 2357
2022
Q4
$682K Buy
39,332
+16,524
+72% +$348K ﹤0.01% 3287
2022
Q3
$556K Buy
22,808
+7,359
+48% +$253K ﹤0.01% 3351
2022
Q2
$478K Buy
15,449
+2,151
+16% +$57.2K ﹤0.01% 3405
2022
Q1
$464K Buy
13,298
+1,456
+12% +$55K ﹤0.01% 3515
2021
Q4
$701K Buy
+11,842
New +$819K ﹤0.01% 3403

Other funds holding CYRX

Ameriprise's CYRX Position: Q4 2025 in Review

Ameriprise sold out of CryoPort (CYRX) in Q4 2025, closing a stake of 45,094 shares — an estimated $427K sold.

Ameriprise first reported a position in CYRX in Q4 2021 and held it in 10 quarters. The position peaked at $4.72M in Q1 2023. 172 funds tracked by Wall St. Rank hold CYRX as of Q4 2025.

  • Ameriprise reported no remaining CryoPort position as of Q4 2025 after selling out during the quarter.
  • Ameriprise sold 45,094 CryoPort shares in Q4 2025, an estimated $427K.
  • Ameriprise first reported a position in CryoPort in Q4 2021 and held it in 10 quarters.
  • Ameriprise's CryoPort position peaked at $4.72M in Q1 2023.
  • 172 funds tracked by Wall St. Rank held CryoPort as of Q4 2025.

Based on Ameriprise's 13F filing for Q4 2025, filed 17 Feb 2026.